The Active Ingredient in Cannabis can Help Patients Regain Appetite and Sense of Taste Preventing Anorexia

“For most cancer patients it has always been thought that the only purpose cannabis provided was to act as a painkiller a recent study has suggested that it can also help the patient regain their appetite and sense of taste. If this is true for cancer patients one must wonder if it is true for AIDS patients and patients with other conditions that allow the use of cannabis as a treatment option.”

cannabis.jpg
 

“Preventing Anorexia

In situations such as cancer and AIDS, patient’s anorexia is a common result for the lack of eating and poor nutrition. Although, anorexia is classified as a mental health condition as you can clearly see there is more than one way to become anorexic. By consuming a product (usually a dessert or candy that is made with cannabis) the patient can enjoy a delicious treat while increasing their appetites.

Possible Treatment for Anorexia

An anorexic also loses their appetite as the stomach shrinks and when food is not consumed for long periods of time the taste buds also decline. We are not suggestion people with anorexia should start smoking cannabis but further research into this area of treatment for anorexics is worth studying.

Conclusion

The original study is for cancer patients and the results showed an increase in the patients appetites and the study is worthy of further study for other conditions including anorexia.”

http://www.eatingdisordersonline.com/news/treatment/the-active-ingredient-in-cannabis-can-help-patients-regain-appetite-and-sense-of 

Naturally occurring and related synthetic cannabinoids and their potential therapeutic applications.

Abstract

“Naturally occurring cannabinoids (phytocannabinoids) are biosynthetically related terpenophenolic compounds uniquely produced by the highly variable plant, Cannabis sativa L. Natural and synthetic cannabinoids have been extensively studied since the discovery that the psychotropic effects of cannabis are mainly due to Delta(9)-THC. However, cannabinoids exert pharmacological actions on other biological systems such as the cardiovascular, immune and endocrine systems. Most of these effects have been attributed to the ability of these compounds to interact with the cannabinoid CB1 and CB2 receptors. The FDA approval of Marinol, a product containing synthetic Delta(9)-THC (dronabinol), in 1985 for the control of nausea and vomiting in cancer patients receiving chemotherapy, and in 1992 as an appetite stimulant for AIDS patients, has further intensified the research interest in these compounds. This article reviews patents (2003-2007) that describe methods for isolation of cannabinoids from cannabis, chemical and chromatographic methods for their purification, synthesis, and potential therapeutic applications of these compounds.”

http://www.ncbi.nlm.nih.gov/pubmed/19519560